Using Diffuse Noxious Inhibitory Control (DNIC) to Predict Acupuncture Therapy Outcome: A Pilot Study

Completed · Not applicable

Conditions studied: Pain

In brief

The investigators hypothesize that acupuncture modifies the DNIC efficiency and that DNIC can serve as a predictor to identify 'good responders' to acupuncture early in therapy.

Key facts

Study ID

NCT01088867

Run by

University of Washington

People needed

10

Starts

2010-03-01

Expected to finish

2010-07-01

Last updated by the study team

2013-06-19

Who can join

Age: 18 and older, up to 60. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• Healthy women with a progesterone-coated intrauterine device (Mirena), and
• Men greater than or equal to 18 years old.

You may not qualify if…

• Acupuncture treatment in the previous six weeks, to discount any persisting effect of acupuncture.
• Treatment of a pain condition with pain medication.
• Regular use of benzodiazepines.
• Skin diseases, such as scleroderma, psoriasis or eczema.
• An adverse event due to acupuncture therapy.
• Pregnant women.
• Women without a progesterone-coated intrauterine device (Mirena).
• Anyone older than 60 years of age, fatigued, with a pacemaker ICD, artificial joint, prolonged bleeding time/hemophilia, open wounds, or a known susceptibility to profound analgesia after acupuncture treatment.

Where it is running

• University of Washington — Seattle, Washington, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.